The WellLab Oxidised LDL test is an advanced biomarker for coronary artery disease. This test measures levels of oxidised low density lipoproteins using a highly sensitive and specific analyses. This test is Low density lipoproteins (LDL), the major carrier of circulating cholesterol, are very susceptible to oxidation. It is seen that elevated oxidised LDL is associated with accelerated atherogenesis, CAD, acute myocardial infarction, stable and unstable angina and metabolic syndrome. This assessment can either be orders as an individual marker or as a combination with LDL subfractions test code 4031.

Common Conditions:

• Coronary Artery Disease
• Heart Attack
• Metabolic Syndrome
• Type 2 Diabetes
• Oxidative Stress
• Family history of heart disease
• High Cholesterol

NOTICE TO PATIENTS

WellLab practices in the usual practitioner-referral system for pathology laboratories. Patients are highly recommended to seek the supervision and guidance of a qualified healthcare practitioner for the interpretation of any lab results and associated information. WellLab can offer assistance in locating a suitable practitioner.

Analytes

Oxidised LDL